Establishing a Standard for Peri-operative Implantable Cardioverter Defibrillator (ICD) Patient Education
- Conditions
- Arrhythmia
- Interventions
- Behavioral: Intervention
- Registration Number
- NCT00845234
- Lead Sponsor
- East Carolina University
- Brief Summary
An implantable cardioverter defibrillator (ICD) administers a shock to terminate potentially life-threatening cardiac arrhythmias. The device saves lives, but presents psychological challenges for patients. At present, there is a paucity of brief interventions for ICD patients designed for administration in a clinic setting that considers issues of cost, time, and available resources. The present study examined the impact of a brief cognitive behavioral (CBT) educational intervention on primary endpoints of patient acceptance and quality of life and secondary endpoints of depression and anxiety. It was hypothesized that the intervention would result in significant improvements primary and secondary endpoints for participants in the intervention group.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 62
- 18+ years old
- literate
- newly implanted with an implantable cardioverter defibrillator (ICD)
- documented neurological sequelae associated with CVA or dementia
- documented cognitive impairment
- reported illiteracy
- previously implanted ICD
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Intervention Group Intervention Intervention group- Patients will receive the brief educational CBT intervention + video and Q\&A session
- Primary Outcome Measures
Name Time Method Score on measure assessing construct of quality of life Up to 8 months after enrollment Quality of life will be obtained via participants scores from the Medical Outcomes Survey Short Form-12 (SF-12) measure of quality of life.
- Secondary Outcome Measures
Name Time Method Score on measure assessing depression Up to 8 months after enrollment Depression will be assessed via participant's self-reported scores on the depression subscale of the Hospital Anxiety and Depression Scale (HADS).
score on measure assessing construct of patient acceptance of device up to 8 months after enrollment The Florida Patient Acceptance Scale measures patient's self-reported acceptance of the implantable cardioverter defibrillator.
score on measure assessing anxiety Up to 8 months after enrollment The Hospital Anxiety and Depression Scale is comprised of two subscales- anxiety and depression. It is a self-report measure that generates a score on the patient's current level of anxiety.
Trial Locations
- Locations (2)
East Carolina Heart Institute
🇺🇸Greenville, North Carolina, United States
Aurora Denver Cardiology Associates
🇺🇸Lone Tree, Colorado, United States